Pular para o conteúdo principal

Busca Avançada Periódicos

Exibindo: 22441 - 22460 de um total de 24762 publiaçãoes
Periódico
Instituto
Entre os anos
Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Population movements, borders, and Chagas disease
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Is the mitochondrion a promising drug target in trypanosomatids?
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Past and future of trypanosomatids high-throughput phenotypic screening
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Computational approaches towards the discovery and optimisation of cruzain inhibitors
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Perspectives for a new drug candidate for Chagas disease therapy
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Article-processing charges as a barrier for science in low-to-medium income regions
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Family Herpesviridae and neuroinfections: current status and research in progress
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022
Genomic surveillance: a potential shortcut for effective Chagas disease management
Memórias do Instituto Oswaldo Cruz
Memorias IOC v. 117 (2022)
v. 117 (2022)
2022